News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
79,169 Results
Type
Article (2492)
Company Profile (8)
Press Release (76668)
Section
Business (18164)
Career Advice (156)
Deals (2583)
Drug Delivery (4)
Drug Development (11514)
Employer Resources (2)
FDA (2301)
Job Trends (1623)
News (34196)
Policy (3058)
Tag
Academia (236)
Accelerated approval (19)
Allergies (45)
Alliances (3927)
ALS (61)
Alzheimer's disease (411)
Antibody-drug conjugate (ADC) (186)
Approvals (2676)
Artificial intelligence (268)
Autoimmune disease (150)
Automation (25)
Bankruptcy (20)
Best Places to Work (1774)
Biosimilars (90)
Biotechnology (5)
Bladder cancer (118)
Brain cancer (15)
Breast cancer (352)
Cancer (2461)
Cardiovascular disease (160)
Career advice (139)
CAR-T (88)
CDC (3)
Cell therapy (246)
Cervical cancer (20)
Clinical research (12371)
Collaboration (847)
Company closure (2)
Compensation (470)
Complete response letters (9)
COVID-19 (382)
CRISPR (43)
C-suite (381)
Cystic fibrosis (43)
Data (3333)
Decentralized trials (1)
Depression (34)
Dermatology (42)
Diabetes (159)
Diagnostics (947)
Digital health (17)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (121)
Drug pricing (19)
Drug shortages (3)
Duchenne muscular dystrophy (81)
Earnings (13738)
Employer resources (1)
Events (12732)
Executive appointments (440)
FDA (3824)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (13)
Funding (628)
Gene editing (84)
Generative AI (17)
Gene therapy (187)
GLP-1 (173)
Government (476)
Grass and pollen (4)
Guidances (179)
Healthcare (1835)
HIV (40)
Huntington's disease (11)
IgA nephropathy (67)
Immunology and inflammation (61)
Immuno-oncology (33)
Indications (68)
Infectious disease (483)
Inflammatory bowel disease (58)
Inflation Reduction Act (3)
Influenza (30)
Intellectual property (72)
Interviews (20)
IPO (1740)
IRA (1)
Job creations (109)
Job search strategy (126)
JPM (2)
Kidney cancer (7)
Labor market (2)
Layoffs (20)
Legal (354)
Liver cancer (27)
Longevity (7)
Lung cancer (392)
Lymphoma (195)
Machine learning (21)
Manufacturing (266)
MASH (50)
Medical device (1288)
Medtech (1327)
Mergers & acquisitions (1289)
Metabolic disorders (342)
mRNA (20)
Multiple sclerosis (57)
NASH (4)
Neurodegenerative disease (144)
Neuropsychiatric disorders (30)
Neuroscience (906)
NextGen: Class of 2026 (443)
Non-profit (362)
Now hiring (13)
Obesity (126)
Opinion (15)
Ovarian cancer (83)
Pain (61)
Pancreatic cancer (111)
Parkinson's disease (129)
Partnered (3)
Patents (132)
Patient recruitment (251)
Peanut (22)
People (5017)
Pharmaceutical (4)
Pharmacy benefit managers (4)
Phase 1 (3598)
Phase 2 (4900)
Phase 3 (4850)
Pipeline (3889)
Policy (5)
Postmarket research (466)
Preclinical (1416)
Press Release (10)
Prostate cancer (130)
Psychedelics (2)
Radiopharmaceuticals (50)
Rare diseases (384)
Real estate (227)
Regulatory (3902)
Reports (7)
Research institute (256)
Resumes & cover letters (24)
Rett syndrome (37)
RNA editing (4)
RSV (29)
Schizophrenia (70)
Series A (99)
Series B (95)
Service/supplier (1)
Sickle cell disease (51)
Spinal muscular atrophy (21)
Sponsored (6)
Startups (235)
Stomach cancer (3)
Supply chain (36)
Tariffs (4)
The Weekly (2)
Vaccines (193)
Venture capital (12)
Weight loss (44)
Women's health (39)
Date
Today (20)
Last 7 days (249)
Last 30 days (1197)
Last 365 days (10569)
2026 (4977)
2025 (11045)
2024 (7279)
2023 (5284)
2022 (6351)
2021 (6157)
2020 (5807)
2019 (4158)
2018 (3225)
2017 (3276)
2016 (2810)
2015 (3221)
2014 (2160)
2013 (1498)
2012 (1574)
2011 (1673)
2010 (1515)
Location
Africa (81)
Alabama (14)
Arizona (42)
Arkansas (5)
Asia (4897)
Australia (574)
California (5370)
Canada (948)
China (428)
Colorado (166)
Connecticut (276)
Delaware (258)
Europe (12669)
Florida (477)
Georgia (91)
Hawaii (3)
Idaho (19)
Illinois (446)
India (36)
Indiana (101)
Iowa (8)
Japan (340)
Kansas (20)
Kentucky (6)
Louisiana (11)
Maine (5)
Maryland (406)
Massachusetts (3982)
Michigan (86)
Minnesota (213)
Mississippi (1)
Missouri (44)
Montana (1)
Nebraska (2)
Nevada (86)
New Hampshire (20)
New Jersey (1344)
New Mexico (7)
New York (1141)
North Carolina (476)
North Dakota (3)
Northern California (2704)
Ohio (140)
Oklahoma (4)
Oregon (7)
Pennsylvania (649)
Puerto Rico (4)
Rhode Island (10)
South America (116)
South Carolina (6)
Southern California (2068)
Tennessee (65)
Texas (756)
United States (16817)
Utah (65)
Virginia (131)
Washington D.C. (26)
Washington State (380)
West Virginia (2)
Wisconsin (102)
79,169 Results for "hoechst a g".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MIMEDX Announces Launch of G4Derm® Plus
May 8, 2026
·
2 min read
Press Releases
CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair
June 2, 2026
·
3 min read
Press Releases
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 18, 2026
·
1 min read
Press Releases
Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026
·
5 min read
Press Releases
Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ASCO 2026
June 1, 2026
·
4 min read
Press Releases
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 20, 2026
·
1 min read
Press Releases
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026
·
1 min read
Press Releases
Canada becomes the first G7 country to approve a generic version of semaglutide
April 29, 2026
·
1 min read
Press Releases
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)
May 29, 2026
·
19 min read
Press Releases
Canada approves second generic semaglutide, the first G7 country to do so
May 4, 2026
·
1 min read
1 of 7,917
Next
